Do analysts recommend NTRB or CVRX?

CVRx has a consensus target price of $11.50, suggesting a potential upside of 125.05%. Given CVRx's stronger consensus rating and higher possible upside, analysts plainly believe CVRx is more favorable than Nutriband. Company Sell Ratings Hold Ratings Buy Ratings Strong Buy Ratings Rating Score Nutriband 1 Sell rating(s) 1 Hold rating(s) 0 Buy rating(s) 0 Strong Buy rating(s) 1.50 CVRx 1 Sell rating(s) 0 Hold rating(s) 1 Buy rating(s) 1 Strong Buy rating(s) 2.67

Which has higher earnings & valuation, NTRB or CVRX?

Nutriband has higher earnings, but lower revenue than CVRx. CVRx is trading at a lower price-to-earnings ratio than Nutriband, indicating that it is currently the more affordable of the two stocks. Company Gross Revenue Price/Sales Ratio Net Income Earnings Per Share Price/Earnings Ratio Nutriband $2.04M 17.70 -$8.23M -$2.58 N/A CVRx $56.65M 2.39 -$53.31M -$2.02 N/A

Is NTRB or CVRX more profitable?

CVRx has a net margin of -89.14% compared to Nutriband's net margin of -448.25%. Nutriband's return on equity of -112.64% beat CVRx's return on equity. Company Net Margins Return on Equity Return on Assets Nutriband -448.25% -112.64% -97.86% CVRx -89.14% -120.76% -48.38%

Do analysts prefer MBOT or NTRB?

Microbot Medical presently has a consensus target price of $6.63, indicating a potential upside of 257.14%. Given Microbot Medical's stronger consensus rating and higher possible upside, research analysts clearly believe Microbot Medical is more favorable than Nutriband. Company Sell Ratings Hold Ratings Buy Ratings Strong Buy Ratings Rating Score Microbot Medical 1 Sell rating(s) 1 Hold rating(s) 2 Buy rating(s) 1 Strong Buy rating(s) 2.60 Nutriband 1 Sell rating(s) 1 Hold rating(s) 0 Buy rating(s) 0 Strong Buy rating(s) 1.50

Do analysts prefer GUTS or NTRB?

Fractyl Health presently has a consensus target price of $5.12, indicating a potential upside of 534.45%. Given Fractyl Health's stronger consensus rating and higher possible upside, research analysts clearly believe Fractyl Health is more favorable than Nutriband. Company Sell Ratings Hold Ratings Buy Ratings Strong Buy Ratings Rating Score Fractyl Health 1 Sell rating(s) 1 Hold rating(s) 4 Buy rating(s) 0 Strong Buy rating(s) 2.50 Nutriband 1 Sell rating(s) 1 Hold rating(s) 0 Buy rating(s) 0 Strong Buy rating(s) 1.50

Is GUTS or NTRB more profitable?

Fractyl Health has a net margin of 0.00% compared to Nutriband's net margin of -448.25%. Nutriband's return on equity of -112.64% beat Fractyl Health's return on equity. Company Net Margins Return on Equity Return on Assets Fractyl Health N/A -4,053.15% -96.41% Nutriband -448.25% -112.64% -97.86%

Do analysts recommend HYPR or NTRB?

Hyperfine currently has a consensus target price of $1.78, indicating a potential upside of 65.89%. Given Hyperfine's stronger consensus rating and higher probable upside, equities analysts clearly believe Hyperfine is more favorable than Nutriband. Company Sell Ratings Hold Ratings Buy Ratings Strong Buy Ratings Rating Score Hyperfine 1 Sell rating(s) 2 Hold rating(s) 3 Buy rating(s) 0 Strong Buy rating(s) 2.33 Nutriband 1 Sell rating(s) 1 Hold rating(s) 0 Buy rating(s) 0 Strong Buy rating(s) 1.50

Is HYPR or NTRB more profitable?

Hyperfine has a net margin of -226.88% compared to Nutriband's net margin of -448.25%. Hyperfine's return on equity of -98.83% beat Nutriband's return on equity. Company Net Margins Return on Equity Return on Assets Hyperfine -226.88% -98.83% -67.09% Nutriband -448.25% -112.64% -97.86%

Do analysts recommend NTRB or LAKE?

Lakeland Industries has a consensus target price of $16.00, indicating a potential upside of 49.53%. Given Lakeland Industries' stronger consensus rating and higher possible upside, analysts clearly believe Lakeland Industries is more favorable than Nutriband. Company Sell Ratings Hold Ratings Buy Ratings Strong Buy Ratings Rating Score Nutriband 1 Sell rating(s) 1 Hold rating(s) 0 Buy rating(s) 0 Strong Buy rating(s) 1.50 Lakeland Industries 1 Sell rating(s) 1 Hold rating(s) 3 Buy rating(s) 0 Strong Buy rating(s) 2.40

Nutriband (NTRB) Competitors

$2.97 +0.03 (+1.02%)

As of 12:21 PM Eastern

Compare

NTRB vs. CVRX, MBOT, GUTS, HYPR, and LAKE

Should you buy Nutriband stock or one of its competitors? MarketBeat compares Nutriband with other companies and stocks that may be similar based on industry, sector, market capitalization, business model, investor interest, or shared news coverage. Companies and stocks commonly compared with Nutriband include CVRx (CVRX), Microbot Medical (MBOT), Fractyl Health (GUTS), Hyperfine (HYPR), and Lakeland Industries (LAKE). These companies are all part of the "medical equipment" industry.

How does Nutriband compare to CVRx?

Nutriband (NASDAQ:NTRB) and CVRx (NASDAQ:CVRX) are both small-cap medical companies, but which is the superior investment? We will contrast the two companies based on the strength of their earnings, dividends, valuation, profitability, risk, analyst recommendations, media sentiment and institutional ownership.

CVRx has a net margin of -89.14% compared to Nutriband's net margin of -448.25%. Nutriband's return on equity of -112.64% beat CVRx's return on equity.

Company	Net Margins	Return on Equity	Return on Assets
Nutriband	-448.25%	-112.64%	-97.86%
CVRx	-89.14%	-120.76%	-48.38%

Nutriband has a beta of 1.93, suggesting that its share price is 93% more volatile than the broader market. Comparatively, CVRx has a beta of 0.81, suggesting that its share price is 19% less volatile than the broader market.

In the previous week, CVRx had 1 more articles in the media than Nutriband. MarketBeat recorded 2 mentions for CVRx and 1 mentions for Nutriband. Nutriband's average media sentiment score of 1.89 beat CVRx's score of 0.93 indicating that Nutriband is being referred to more favorably in the media.

Company	Overall Sentiment
Nutriband	Very Positive
CVRx	Positive

19.7% of Nutriband shares are held by institutional investors. Comparatively, 75.3% of CVRx shares are held by institutional investors. 52.2% of Nutriband shares are held by insiders. Comparatively, 18.9% of CVRx shares are held by insiders. Strong institutional ownership is an indication that large money managers, hedge funds and endowments believe a company will outperform the market over the long term.

Nutriband has higher earnings, but lower revenue than CVRx. CVRx is trading at a lower price-to-earnings ratio than Nutriband, indicating that it is currently the more affordable of the two stocks.

Company	Gross Revenue	Price/Sales Ratio	Net Income	Earnings Per Share	Price/Earnings Ratio
Nutriband	$2.04M	17.70	-$8.23M	-$2.58	N/A
CVRx	$56.65M	2.39	-$53.31M	-$2.02	N/A

CVRx has a consensus target price of $11.50, suggesting a potential upside of 125.05%. Given CVRx's stronger consensus rating and higher possible upside, analysts plainly believe CVRx is more favorable than Nutriband.

Company	Sell Ratings	Hold Ratings	Buy Ratings	Strong Buy Ratings	Rating Score
Nutriband	1 Sell rating(s)	1 Hold rating(s)	0 Buy rating(s)	0 Strong Buy rating(s)	1.50
CVRx	1 Sell rating(s)	0 Hold rating(s)	1 Buy rating(s)	1 Strong Buy rating(s)	2.67

Summary

CVRx beats Nutriband on 10 of the 17 factors compared between the two stocks.

How does Nutriband compare to Microbot Medical?

Microbot Medical (NASDAQ:MBOT) and Nutriband (NASDAQ:NTRB) are both small-cap medical companies, but which is the superior business? We will contrast the two businesses based on the strength of their profitability, risk, earnings, dividends, valuation, analyst recommendations, institutional ownership and media sentiment.

In the previous week, Microbot Medical had 1 more articles in the media than Nutriband. MarketBeat recorded 2 mentions for Microbot Medical and 1 mentions for Nutriband. Nutriband's average media sentiment score of 1.89 beat Microbot Medical's score of 1.08 indicating that Nutriband is being referred to more favorably in the news media.

Company	Overall Sentiment
Microbot Medical	Positive
Nutriband	Very Positive

Nutriband has higher revenue and earnings than Microbot Medical. Microbot Medical is trading at a lower price-to-earnings ratio than Nutriband, indicating that it is currently the more affordable of the two stocks.

Company	Gross Revenue	Price/Sales Ratio	Net Income	Earnings Per Share	Price/Earnings Ratio
Microbot Medical	N/A	N/A	-$13.14M	-$0.26	N/A
Nutriband	$2.04M	17.70	-$8.23M	-$2.58	N/A

Microbot Medical has a net margin of 0.00% compared to Nutriband's net margin of -448.25%. Microbot Medical's return on equity of -21.84% beat Nutriband's return on equity.

Company	Net Margins	Return on Equity	Return on Assets
Microbot Medical	N/A	-21.84%	-20.71%
Nutriband	-448.25%	-112.64%	-97.86%

Microbot Medical presently has a consensus target price of $6.63, indicating a potential upside of 257.14%. Given Microbot Medical's stronger consensus rating and higher possible upside, research analysts clearly believe Microbot Medical is more favorable than Nutriband.

Company	Sell Ratings	Hold Ratings	Buy Ratings	Strong Buy Ratings	Rating Score
Microbot Medical	1 Sell rating(s)	1 Hold rating(s)	2 Buy rating(s)	1 Strong Buy rating(s)	2.60
Nutriband	1 Sell rating(s)	1 Hold rating(s)	0 Buy rating(s)	0 Strong Buy rating(s)	1.50

Microbot Medical has a beta of 1.04, meaning that its stock price is 4% more volatile than the broader market. Comparatively, Nutriband has a beta of 1.93, meaning that its stock price is 93% more volatile than the broader market.

16.3% of Microbot Medical shares are held by institutional investors. Comparatively, 19.7% of Nutriband shares are held by institutional investors. 4.7% of Microbot Medical shares are held by company insiders. Comparatively, 52.2% of Nutriband shares are held by company insiders. Strong institutional ownership is an indication that endowments, hedge funds and large money managers believe a company is poised for long-term growth.

Summary

Microbot Medical beats Nutriband on 9 of the 16 factors compared between the two stocks.

How does Nutriband compare to Fractyl Health?

Fractyl Health (NASDAQ:GUTS) and Nutriband (NASDAQ:NTRB) are both small-cap medical companies, but which is the superior stock? We will contrast the two companies based on the strength of their profitability, valuation, risk, dividends, institutional ownership, media sentiment, analyst recommendations and earnings.

Fractyl Health has a net margin of 0.00% compared to Nutriband's net margin of -448.25%. Nutriband's return on equity of -112.64% beat Fractyl Health's return on equity.

Company	Net Margins	Return on Equity	Return on Assets
Fractyl Health	N/A	-4,053.15%	-96.41%
Nutriband	-448.25%	-112.64%	-97.86%

Fractyl Health has a beta of 2.29, indicating that its stock price is 129% more volatile than the broader market. Comparatively, Nutriband has a beta of 1.93, indicating that its stock price is 93% more volatile than the broader market.

Fractyl Health presently has a consensus target price of $5.12, indicating a potential upside of 534.45%. Given Fractyl Health's stronger consensus rating and higher possible upside, research analysts clearly believe Fractyl Health is more favorable than Nutriband.

Company	Sell Ratings	Hold Ratings	Buy Ratings	Strong Buy Ratings	Rating Score
Fractyl Health	1 Sell rating(s)	1 Hold rating(s)	4 Buy rating(s)	0 Strong Buy rating(s)	2.50
Nutriband	1 Sell rating(s)	1 Hold rating(s)	0 Buy rating(s)	0 Strong Buy rating(s)	1.50

Nutriband has higher revenue and earnings than Fractyl Health. Nutriband is trading at a lower price-to-earnings ratio than Fractyl Health, indicating that it is currently the more affordable of the two stocks.

Company	Gross Revenue	Price/Sales Ratio	Net Income	Earnings Per Share	Price/Earnings Ratio
Fractyl Health	$90K	1,422.56	-$140.95M	-$1.29	N/A
Nutriband	$2.04M	17.70	-$8.23M	-$2.58	N/A

In the previous week, Fractyl Health had 2 more articles in the media than Nutriband. MarketBeat recorded 3 mentions for Fractyl Health and 1 mentions for Nutriband. Nutriband's average media sentiment score of 1.89 beat Fractyl Health's score of 0.88 indicating that Nutriband is being referred to more favorably in the news media.

Company	Overall Sentiment
Fractyl Health	Positive
Nutriband	Very Positive

19.7% of Nutriband shares are held by institutional investors. 8.5% of Fractyl Health shares are held by company insiders. Comparatively, 52.2% of Nutriband shares are held by company insiders. Strong institutional ownership is an indication that large money managers, endowments and hedge funds believe a company is poised for long-term growth.

Summary

Fractyl Health beats Nutriband on 10 of the 16 factors compared between the two stocks.

How does Nutriband compare to Hyperfine?

Hyperfine (NASDAQ:HYPR) and Nutriband (NASDAQ:NTRB) are both small-cap medical companies, but which is the better investment? We will contrast the two businesses based on the strength of their valuation, dividends, institutional ownership, risk, media sentiment, profitability, analyst recommendations and earnings.

Hyperfine has a beta of 1.4, suggesting that its share price is 40% more volatile than the broader market. Comparatively, Nutriband has a beta of 1.93, suggesting that its share price is 93% more volatile than the broader market.

In the previous week, Hyperfine had 1 more articles in the media than Nutriband. MarketBeat recorded 2 mentions for Hyperfine and 1 mentions for Nutriband. Nutriband's average media sentiment score of 1.89 beat Hyperfine's score of 0.44 indicating that Nutriband is being referred to more favorably in the news media.

Company	Overall Sentiment
Hyperfine	Neutral
Nutriband	Very Positive

15.0% of Hyperfine shares are owned by institutional investors. Comparatively, 19.7% of Nutriband shares are owned by institutional investors. 26.3% of Hyperfine shares are owned by insiders. Comparatively, 52.2% of Nutriband shares are owned by insiders. Strong institutional ownership is an indication that endowments, hedge funds and large money managers believe a company is poised for long-term growth.

Hyperfine currently has a consensus target price of $1.78, indicating a potential upside of 65.89%. Given Hyperfine's stronger consensus rating and higher probable upside, equities analysts clearly believe Hyperfine is more favorable than Nutriband.

Company	Sell Ratings	Hold Ratings	Buy Ratings	Strong Buy Ratings	Rating Score
Hyperfine	1 Sell rating(s)	2 Hold rating(s)	3 Buy rating(s)	0 Strong Buy rating(s)	2.33
Nutriband	1 Sell rating(s)	1 Hold rating(s)	0 Buy rating(s)	0 Strong Buy rating(s)	1.50

Hyperfine has a net margin of -226.88% compared to Nutriband's net margin of -448.25%. Hyperfine's return on equity of -98.83% beat Nutriband's return on equity.

Company	Net Margins	Return on Equity	Return on Assets
Hyperfine	-226.88%	-98.83%	-67.09%
Nutriband	-448.25%	-112.64%	-97.86%

Nutriband has lower revenue, but higher earnings than Hyperfine. Hyperfine is trading at a lower price-to-earnings ratio than Nutriband, indicating that it is currently the more affordable of the two stocks.

Company	Gross Revenue	Price/Sales Ratio	Net Income	Earnings Per Share	Price/Earnings Ratio
Hyperfine	$11.40M	9.36	-$35.57M	-$0.41	N/A
Nutriband	$2.04M	17.70	-$8.23M	-$2.58	N/A

Summary

Hyperfine beats Nutriband on 9 of the 16 factors compared between the two stocks.

How does Nutriband compare to Lakeland Industries?

Nutriband (NASDAQ:NTRB) and Lakeland Industries (NASDAQ:LAKE) are both small-cap medical equipment companies, but which is the superior stock? We will contrast the two companies based on the strength of their earnings, profitability, analyst recommendations, media sentiment, dividends, institutional ownership, valuation and risk.

Lakeland Industries has a consensus target price of $16.00, indicating a potential upside of 49.53%. Given Lakeland Industries' stronger consensus rating and higher possible upside, analysts clearly believe Lakeland Industries is more favorable than Nutriband.

Company	Sell Ratings	Hold Ratings	Buy Ratings	Strong Buy Ratings	Rating Score
Nutriband	1 Sell rating(s)	1 Hold rating(s)	0 Buy rating(s)	0 Strong Buy rating(s)	1.50
Lakeland Industries	1 Sell rating(s)	1 Hold rating(s)	3 Buy rating(s)	0 Strong Buy rating(s)	2.40

Lakeland Industries has a net margin of -10.87% compared to Nutriband's net margin of -448.25%. Lakeland Industries' return on equity of -6.64% beat Nutriband's return on equity.

Company	Net Margins	Return on Equity	Return on Assets
Nutriband	-448.25%	-112.64%	-97.86%
Lakeland Industries	-10.87%	-6.64%	-4.13%

19.7% of Nutriband shares are owned by institutional investors. Comparatively, 71.7% of Lakeland Industries shares are owned by institutional investors. 52.2% of Nutriband shares are owned by company insiders. Comparatively, 3.4% of Lakeland Industries shares are owned by company insiders. Strong institutional ownership is an indication that endowments, large money managers and hedge funds believe a company is poised for long-term growth.

Nutriband has a beta of 1.93, meaning that its stock price is 93% more volatile than the broader market. Comparatively, Lakeland Industries has a beta of 1.45, meaning that its stock price is 45% more volatile than the broader market.

Nutriband has higher earnings, but lower revenue than Lakeland Industries. Lakeland Industries is trading at a lower price-to-earnings ratio than Nutriband, indicating that it is currently the more affordable of the two stocks.

Company	Gross Revenue	Price/Sales Ratio	Net Income	Earnings Per Share	Price/Earnings Ratio
Nutriband	$2.04M	17.70	-$8.23M	-$2.58	N/A
Lakeland Industries	$192.65M	0.55	-$25.31M	-$2.13	N/A

In the previous week, Lakeland Industries had 2 more articles in the media than Nutriband. MarketBeat recorded 3 mentions for Lakeland Industries and 1 mentions for Nutriband. Nutriband's average media sentiment score of 1.89 beat Lakeland Industries' score of 0.57 indicating that Nutriband is being referred to more favorably in the media.

Company	Overall Sentiment
Nutriband	Very Positive
Lakeland Industries	Positive

Summary

Lakeland Industries beats Nutriband on 10 of the 16 factors compared between the two stocks.

Get Nutriband News Delivered to You Automatically

Subscribe Now

SMS is currently available in Australia, Belgium, Canada, France, Germany, Ireland, Italy, New Zealand, the Netherlands, Singapore, South Africa, Spain, Switzerland, the United Kingdom, and the United States. By entering your phone number and clicking the sign-up button, you agree to receive periodic text messages from MarketBeat at the phone number you submitted, including texts that may be sent using an automatic telephone dialing system. Message and data rates may apply. Message frequency will vary. Messages will consist of stock alerts, news stories, and partner advertisements/offers. Consent is not a condition of the purchase of any goods or services. Text HELP for help/customer support. Unsubscribe at any time by replying "STOP" to any text message that you receive from MarketBeat or by visiting our mailing preferences page. Read our full terms of service and privacy policy.

New MarketBeat Followers Over Time

This chart shows the number of new MarketBeat users adding NTRB and its top 5 competitors to their watchlist. Each company is represented with a line over a 90 day period.

Media Sentiment Over Time

This chart shows the average media sentiment of NASDAQ and its competitors over the past 90 days as caculated by MarketBeat. The averaged score is equivalent to the following: Very Negative Sentiment <= -1.5, Negative Sentiment > -1.5 and <= -0.5, Neutral Sentiment > -0.5 and < 0.5, Positive Sentiment >= 0.5 and < 1.5, and Very Positive Sentiment >= 1.5.

NTRB vs. The Competition

Export

Metric	Nutriband	MED Industry	Medical Sector	NASDAQ Exchange
Market Cap	$35.93M	$2.99B	$6.74B	$12.51B
Dividend Yield	N/A	2.06%	2.68%	8.00%
P/E Ratio	-1.15	18.66	26.90	24.39
Price / Sales	17.70	822.95	587.69	117.46
Price / Cash	N/A	56.80	29.22	49.36
Price / Book	5.40	4.22	10.92	6.33
Net Income	-$8.23M	$64.26M	$3.58B	$330.66M
7 Day Performance	-2.01%	-3.42%	-2.25%	-0.84%
1 Month Performance	-12.42%	2.26%	3.08%	-0.26%
1 Year Performance	-63.07%	20.47%	26.23%	19.99%

Nutriband Competitors List

Export

Company	MarketRank	Share Price	Analysts' Price Target	1Y Price Performance	Market Cap	Revenue	P/E Ratio	Employee Count	Indicator(s)
NTRB Nutriband	0.9847 of 5 stars	$2.97 +1.0%	N/A	-63.1%	$36.16M	$2.04M	N/A	10	Gap Up
CVRX CVRx	2.0245 of 5 stars	$5.74 +2.0%	$11.50 +100.3%	-20.5%	$149.40M	$56.65M	N/A	160
MBOT Microbot Medical	2.5451 of 5 stars	$1.90 -1.6%	$6.63 +248.7%	-28.2%	$129.63M	N/A	N/A	20	Analyst Forecast Gap Up
GUTS Fractyl Health	4.2399 of 5 stars	$0.80 -1.2%	$5.12 +543.2%	-49.9%	$127.86M	$90K	N/A	102
HYPR Hyperfine	2.7906 of 5 stars	$1.22 -3.9%	$1.78 +46.2%	+36.5%	$126.07M	$11.40M	N/A	190	Short Interest Increase

Related Companies and Tools

Related Companies

Top 10 Stock Comparisons

This page (NASDAQ:NTRB) was last updated on 7/14/2026 by MarketBeat.com Staff.

From Our Partners

Unlock superior investment research and tools.

Get MarketBeat All Access

In-depth profiles and analysis for 20,000 public companies.
Real-time analyst ratings, insider transactions, earnings data, and more.
Our daily ratings and market update email newsletter.

Sign In
Create Account

Your Email Address:

Your Password:

Forgot your password?

Your Email Address:

Choose a Password:

By creating a free account, you agree to our terms of service. This site is protected by reCAPTCHA and the Google Privacy Policy and Terms of Service apply.

Nutriband (NTRB) Competitors

NTRB vs. CVRX, MBOT, GUTS, HYPR, and LAKE

How does Nutriband compare to CVRx?

Summary

How does Nutriband compare to Microbot Medical?

Summary

How does Nutriband compare to Fractyl Health?

Summary

How does Nutriband compare to Hyperfine?

Summary

How does Nutriband compare to Lakeland Industries?

Summary

New MarketBeat Followers Over Time

Media Sentiment Over Time

NTRB vs. The Competition

Nutriband Competitors List

Related Companies and Tools

Best-in-Class Portfolio Monitoring

Stock Ideas and Recommendations

Advanced Stock Screeners and Research Tools

About MarketBeat

MarketBeat Products

Popular Tools

Financial Calendars

Terms & Info

Nutriband (NTRB) Competitors

NTRB vs. CVRX, MBOT, GUTS, HYPR, and LAKE

How does Nutriband compare to CVRx?

Is NTRB or CVRX more profitable?

Which has more risk and volatility, NTRB or CVRX?

Does the media refer more to NTRB or CVRX?

Do insiders and institutionals hold more shares of NTRB or CVRX?

Which has higher earnings & valuation, NTRB or CVRX?

Do analysts recommend NTRB or CVRX?

Summary

How does Nutriband compare to Microbot Medical?

Does the media favor MBOT or NTRB?

Which has stronger valuation and earnings, MBOT or NTRB?

Is MBOT or NTRB more profitable?

Do analysts prefer MBOT or NTRB?

Which has more risk and volatility, MBOT or NTRB?

Do insiders & institutionals hold more shares of MBOT or NTRB?

Summary

How does Nutriband compare to Fractyl Health?

Is GUTS or NTRB more profitable?

Which has more risk & volatility, GUTS or NTRB?

Do analysts prefer GUTS or NTRB?

Which has preferable valuation and earnings, GUTS or NTRB?

Does the media prefer GUTS or NTRB?

Do insiders and institutionals believe in GUTS or NTRB?

Summary

How does Nutriband compare to Hyperfine?

Which has more volatility and risk, HYPR or NTRB?

Does the media refer more to HYPR or NTRB?

Do insiders and institutionals believe in HYPR or NTRB?

Do analysts recommend HYPR or NTRB?

Is HYPR or NTRB more profitable?

Which has stronger earnings & valuation, HYPR or NTRB?

Summary

How does Nutriband compare to Lakeland Industries?

Do analysts recommend NTRB or LAKE?

Is NTRB or LAKE more profitable?

Do insiders & institutionals believe in NTRB or LAKE?

Which has more volatility & risk, NTRB or LAKE?

Which has stronger valuation & earnings, NTRB or LAKE?

Does the media favor NTRB or LAKE?

Summary

New MarketBeat Followers Over Time

Media Sentiment Over Time

NTRB vs. The Competition

Nutriband Competitors List

Related Companies and Tools

MarketBeat All Access Features

Best-in-Class Portfolio Monitoring

Stock Ideas and Recommendations

Advanced Stock Screeners and Research Tools